Axsome Therapeutics (AXSM) Short Interest Ratio & Short Volume → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free AXSM Stock Alerts $79.80 +0.63 (+0.80%) (As of 03/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Axsome Therapeutics Short Interest DataCurrent Short Volume7,300,000 sharesPrevious Short Volume7,470,000 sharesChange Vs. Previous Month-2.28%Dollar Volume Sold Short$551.44 millionShort Interest Ratio / Days to Cover9.4Last Record DateMarch 15, 2024Outstanding Shares47,370,000 sharesPercentage of Shares Shorted15.41%Today's Trading Volume487,570 sharesAverage Trading Volume899,398 sharesToday's Volume Vs. Average54% Short Selling Axsome Therapeutics ? Sign up to receive the latest short interest report for Axsome Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAXSM Short Interest Over TimeAXSM Days to Cover Over TimeAXSM Percentage of Float Shorted Over Time Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Axsome Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20247,300,000 shares $551.44 million -2.3%N/A9.4 $75.54 2/29/20247,470,000 shares $607.91 million -0.7%N/A10.2 $81.38 2/15/20247,520,000 shares $702.82 million +0.4%N/A10.9 $93.46 1/31/20247,490,000 shares $674.32 million -10.0%N/A11.5 $90.03 1/15/20248,320,000 shares $708.95 million -1.2%N/A11.9 $85.21 12/31/20238,420,000 shares $670.15 million +0.7%N/A12.4 $79.59 Get the Latest News and Ratings for AXSM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Axsome Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/15/20238,360,000 shares $610.20 million -1.1%N/A12.6 $72.99 11/30/20238,450,000 shares $569.95 million +10.6%N/A12.3 $67.45 11/15/20237,640,000 shares $460.00 million +4.0%N/A11.5 $60.21 10/31/20237,350,000 shares $457.76 million -3.2%N/A11 $62.28 10/15/20237,590,000 shares $504.51 million +1.6%N/A10.9 $66.47 9/30/20237,470,000 shares $522.08 million -8.0%N/A10.4 $69.89 9/15/20238,120,000 shares $611.11 million -1.5%N/A9.6 $75.26 8/31/20238,240,000 shares $665.79 million -3.5%N/A9.3 $80.80 8/15/20238,540,000 shares $609.41 million -5.7%N/A9.4 $71.36 7/31/20239,060,000 shares $710.94 million -2.6%N/A9.6 $78.47 7/15/20239,300,000 shares $684.76 million +1.8%N/A10.5 $73.63 6/30/20239,140,000 shares $656.80 million +17.8%24.5%10.1 $71.86 6/15/20237,760,000 shares $656.73 million +0.3%22.2%9.9 $84.63 5/31/20237,740,000 shares $571.06 million +0.9%22.2%9.9 $73.78 5/15/20237,670,000 shares $596.50 million -4.0%22.0%9.1 $77.77 4/30/20237,990,000 shares $571.52 million +1.9%23.3%8.9 $71.53 4/15/20237,840,000 shares $537.04 million -4.5%22.8%8.6 $68.50 3/31/20238,210,000 shares $506.39 million -3.8%23.9%8.7 $61.68 3/15/20238,530,000 shares $528.26 million +1.6%24.8%8.9 $61.93 2/28/20238,400,000 shares $572.80 million +4.4%24.5%8.5 $68.19 2/15/20238,050,000 shares $508.28 million +5.4%23.5%6.9 $63.14 1/31/20237,640,000 shares $573 million -3.8%21.6%6.2 $75.00 1/15/20237,940,000 shares $534.36 million +5.2%22.4%5.9 $67.30 12/30/20227,550,000 shares $582.33 million +2.4%21.3%5.4 $77.13 12/15/20227,370,000 shares $570.88 million -7.1%20.8%5.1 $77.46 11/30/20227,930,000 shares $573.26 million +16.8%22.8%5.3 $72.29 11/15/20226,790,000 shares $372.91 million +9.0%19.5%5.2 $54.92 10/31/20226,230,000 shares $281.28 million +8.5%19.3%3.6 $45.15 10/15/20225,740,000 shares $275.52 million +2.5%17.8%3.7 $48.00 9/30/20225,600,000 shares $249.87 million -1.8%17.4%3.8 $44.62 9/15/20225,700,000 shares $351.63 million -3.7%17.7%2.9 $61.69 8/31/20225,920,000 shares $377.70 million +8.4%18.5%3.1 $63.80 8/15/20225,460,000 shares $258.64 million -5.0%17.1%3 $47.37 7/31/20225,750,000 shares $221.89 million -3.9%18.7%4.2 $38.59Central Banks Preparing for US Dollar Collapse? (Ad)China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>> AXSM Short Interest - Frequently Asked Questions What is Axsome Therapeutics' current short interest? Short interest is the volume of Axsome Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 7,300,000 shares of AXSM short. Learn More on Axsome Therapeutics' current short interest. What is a good short interest ratio for Axsome Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AXSM shares currently have a short interest ratio of 9.0. Learn More on Axsome Therapeutics's short interest ratio. Which institutional investors are shorting Axsome Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Axsome Therapeutics: Goldman Sachs Group Inc., GTS Securities LLC, Barclays PLC, Wolverine Trading LLC, Citadel Advisors LLC, Goldman Sachs Group Inc., Concourse Financial Group Securities Inc., Simplex Trading LLC, SpiderRock Advisors LLC, and Cutler Group LLC CA. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Axsome Therapeutics' short interest increasing or decreasing? Axsome Therapeutics saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 7,300,000 shares, a drop of 2.3% from the previous total of 7,470,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Axsome Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Axsome Therapeutics: Bausch Health Companies Inc. (6.67%), Prestige Consumer Healthcare Inc. (3.79%), CymaBay Therapeutics, Inc. (5.10%), Ultragenyx Pharmaceutical Inc. (4.59%), Arrowhead Pharmaceuticals, Inc. (7.43%), Amicus Therapeutics, Inc. (10.97%), Insmed Incorporated (5.95%), Xenon Pharmaceuticals Inc. (3.47%), MoonLake Immunotherapeutics (14.83%), IDEAYA Biosciences, Inc. (13.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Axsome Therapeutics stock? Short selling AXSM is an investing strategy that aims to generate trading profit from Axsome Therapeutics as its price is falling. AXSM shares are trading up $0.63 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Axsome Therapeutics? A short squeeze for Axsome Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AXSM, which in turn drives the price of the stock up even further. How often is Axsome Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AXSM, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Bausch Health Companies Short Interest Prestige Consumer Healthcare Short Interest CymaBay Therapeutics Short Interest Ultragenyx Pharmaceutical Short Interest Arrowhead Pharmaceuticals Short Interest Amicus Therapeutics Short Interest Insmed Short Interest Xenon Pharmaceuticals Short Interest MoonLake Immunotherapeutics Short Interest IDEAYA Biosciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AXSM) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company